These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34017413)

  • 1. Correlation of CD3+/CD4+, and serum CK-18 fragment levels with glucose and lipid metabolism in elderly type 2 diabetes patients with nonalcoholic fatty liver disease.
    Zhao C; Lou F; Li X; Ma J; Zhu Z; Li H; Zhai Y; Chen H; Zhang Q; Liu Z; Xiao S
    Am J Transl Res; 2021; 13(4):2546-2554. PubMed ID: 34017413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.
    Zhang Z; Wang J; Wang H
    Exp Ther Med; 2018 Mar; 15(3):2936-2940. PubMed ID: 29456698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.
    Li YL; Xie H; Musha H; Xing Y; Mei CX; Wang HJ; Wulasihan M
    Cell Biochem Biophys; 2015 Jul; 72(3):643-7. PubMed ID: 27352181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of multiple lipid and lipoprotein ratios with nonalcoholic fatty liver disease in patients with newly diagnosed type 2 diabetic mellitus: A retrospective study.
    Li R; Kong D; Ye Z; Zong G; Hu K; Xu W; Fang P; Zhang L; Zhou Y; Zhang K; Xue Y
    Front Endocrinol (Lausanne); 2023; 14():1127134. PubMed ID: 36875464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Nonalcoholic Fatty Liver Disease in Postmenopausal Women with Type 2 Diabetes Mellitus and the Correlation with Bone Mineral Density at Different Locations.
    Du YJ; Liu NN; Zhong X; Pan TR
    Diabetes Metab Syndr Obes; 2022; 15():1925-1934. PubMed ID: 35761888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].
    Shao Y; Xu JY; Lu XL; Chen J; Li T; Wang YT; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):867-872. PubMed ID: 34638206
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients.
    Zhou X; Luo M; Zhou S; Cheng Z; Chen Z; Yu X
    Diabetes Metab Syndr Obes; 2021; 14():379-385. PubMed ID: 33536771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
    Chen Y; Wang XJ; Jin HL; Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinico-pathological features and related risk factors of Type-2 diabetes mellitus complicated with nonalcoholic fatty liver.
    Chen L; Jiang L
    Pak J Med Sci; 2022; 38(7):1771-1775. PubMed ID: 36246713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytokeratin-18 fragment level as a biomarker of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Miyasato M; Murase-Mishiba Y; Bessho M; Miyawaki M; Imbe H; Tsutsumi C; Tanimoto K; Imagawa A; Terasaki J; Hanafusa T
    Clin Chim Acta; 2014 Jun; 433():184-9. PubMed ID: 24667697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miR-513a-5p as a Potential Biomarker for Diagnosis of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients.
    Li F; Wu X; Zhang Y; Wei K
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial].
    Dong C; Zhang CR; Xue BY; Miu WF; Fang NY; Li K; Ou ZJ; Xu YQ
    Zhongguo Zhen Jiu; 2020 Feb; 40(2):129-34. PubMed ID: 32100496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease.
    Sun T; Wang C; Huo L; Wang Y; Liu K; Wei C; Zhao H; Chen S; Ren L
    Int J Gen Med; 2023; 16():631-639. PubMed ID: 36851999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 19. The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study.
    Emamgholipour S; Moradi N; Beigy M; Shabani P; Fadaei R; Poustchi H; Doosti M
    Diabetol Metab Syndr; 2015; 7():108. PubMed ID: 26613006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma 12,13-diHOME level and nonalcoholic fatty liver disease in patients with type 2 diabetes and obesity.
    Wang S; Sun W; Cheng Y; Wang L; Ma S; Jing F; Zhang X; Zhou X
    Minerva Endocrinol (Torino); 2021 Apr; ():. PubMed ID: 33855386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.